HomePHAT • NASDAQ
add
Phathom Pharmaceuticals Inc
Previous close
$6.95
Day range
$6.73 - $7.11
Year range
$6.07 - $19.71
Market cap
474.54M USD
Avg Volume
954.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 16.35M | — |
Operating expense | 84.79M | 137.79% |
Net income | -85.58M | -97.90% |
Net profit margin | -523.34 | — |
Earnings per share | -1.05 | -38.16% |
EBITDA | -70.60M | -98.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 334.68M | 56.63% |
Total assets | 387.04M | 63.32% |
Total liabilities | 574.16M | 125.37% |
Total equity | -187.11M | — |
Shares outstanding | 68.38M | — |
Price to book | -2.54 | — |
Return on assets | -50.11% | — |
Return on capital | -58.56% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -85.58M | -97.90% |
Cash from operations | -63.57M | -99.20% |
Cash from investing | -44.00K | 95.31% |
Cash from financing | 122.06M | 938,800.00% |
Net change in cash | 58.44M | 277.95% |
Free cash flow | -52.23M | -96.33% |
About
Founded
2018
Headquarters
Website
Employees
452
